Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Manganic porphyrins for treatment of hyperoxic lung injury

May 8, 1998

CNRS investigators discover CFTR channel activators

May 8, 1998

Antiallergic/antiinflammatory effects of heparin and heparin fractions under evaluation

May 7, 1998

Spotlight on NK antagonists for asthma

May 7, 1998

PDE IV inhibitors focus of attention at recent respiratory care congress

May 7, 1998

Phosphodiesterase inhibitors with antiasthmatic efficacy

May 7, 1998

CytoMed's 5-LO inhibitor shows potential in asthma; clinical trials imminent

May 6, 1998

SB-240563, an anti-IL-5 MAb for the treatment of asthma

May 6, 1998

Spotlight on P2Y2 agonists: a new target for cystic fibrosis

May 6, 1998

Surfaxin as ARDS treatment enters phase II/III

May 5, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...